Arjun Agarwal is President & VP at Oruka Therapeutics, Inc. (ORKA). They have made 1 open-market trade across 1 company since 2026, most recently 2026-10-12.
CIK 0002033974
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ORKA | 14,219 | $1.0M |
Shares reported on the most recent Form 4, priced at the 2026-10-13 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ORKA | SELL · 10b5-1 | 2026-10-12 | 2026-10-13 | $80.60 | $806K | — | — | — |
| ORKA | SELL · 10b5-1 | 2026-09-21 | 2026-09-21 | $95.75 | $51K | -12.0% | — | — |
| ORKA | SELL · 10b5-1 | 2026-09-11 | 2026-09-15 | $92.43 | $926K | -9.1% | -20.5% | — |
| ORKA | SELL · 10b5-1 | 2026-08-13 | 2026-08-14 | $106.66 | $1.1M | -9.6% | -12.8% | — |
| ORKA | SELL · 10b5-1 | 2026-07-13 | 2026-07-13 | $84.63 | $846K | +7.6% | +25.5% | -5.9% |
| ORKA | SELL · 10b5-1 | 2026-06-22 | 2026-06-22 | $80.95 | $128K | +0.8% | +9.5% | +10.4% |
| ORKA | SELL · 10b5-1 | 2026-06-12 | 2026-06-15 | $69.72 | $687K | +32.0% | +26.3% | +39.8% |
| ORKA | SELL · 10b5-1 | 2026-05-18 | 2026-05-18 | $59.07 | $608K | +3.0% | +24.7% | +98.4% |
| ORKA | SELL | 2026-03-16 | 2026-03-17 | $41.30 | $16K | +7.8% | +62.5% | +67.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.